Tesamorelin meta-analysis in HIV-associated lipodystrophy
study094
10.1007/s12020-024-03971-7
Endocrine
meta-analysis
Meta-analysis assessed efficacy and safety of tesamorelin in HIV-associated lipodystrophy.
Tesamorelin increased lean mass and reduced visceral adipose tissue with predictable IGF-1 changes.
tesamorelin
fat-loss|hormone-optimization
gh-optimization-stack
tesamorelin-vs-sermorelin
published